| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2002;74:988-994
© 2002 The Society of Thoracic Surgeons
a Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
* Address reprint requests to Dr Battafarano, Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, One Barnes-Jewish Plaza, 3107 Queeny Tower, St. Louis, MO 63110-1013 USA
e-mail: battafarano{at}msnotes.wustl.edu
Presented at the Thirty-eighth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 28–30, 2002.
Background. Revisions in the international system for the staging of lung cancer, adopted in 1997, assigned the T4 descriptor to separate tumor nodules in the same lobe and the M1 descriptor to tumor nodules in a different lobe. Consequently, these changes shifted the stage of patients with these lesions to stage IIIB or stage IV. The goal of this review was to determine the impact of multifocal non-small cell lung cancer on survival.
Methods. A database analysis of our cardiothoracic surgery tumor registry was performed to identify all patients who underwent surgical resection of non-small cell lung cancer (NSCLC), who were ultimately determined to have pathologically node-negative disease from 1994 to 1999. All pathology reports were individually reviewed. Survival data were collected on each patient from the date of surgery with a mean duration of follow-up of 46.3 months. Kaplan Meier actuarial survival was determined for all patients.
Results. Forty-four patients were identified who underwent complete resection of multiple NSCLC tumors. During this same period, 504 patients underwent complete resection of stage I NSCLC tumors. The 3-year actuarial survival for patients with T1/N0/M0 tumors was 79.6%. In comparison with patients with T1/N0/M0 tumors, the 3-year actuarial survival rates of patients with T2/N0/M0 tumors (72.3%, p = 0.056), T4/N0/M0 tumors (66.5%, p = 0.058), and T1 to T2/N0/M1 tumors (63.6%, p = 0.201) were lower. However, these differences did not achieve statistical significance.
Conclusions. Although there was a trend toward decreased survival in patients with multifocal NSCLC compared with patients with stage I NSCLC, this did not achieve statistical significance. Importantly, survival in these subgroups of patients with stage IIIB or stage IV disease (stage determined solely on the basis of multifocal NSCLC) is better than the survival reported in the series that formed the foundation for these staging changes. These data support complete surgical resection of multifocal lung tumors in patients with node-negative NSCLC.
This article has been cited by other articles:
|
|
 |
|
  X. Wang, M. Wang, G. T. MacLennan, F. W. Abdul-Karim, J. N. Eble, T. D. Jones, F. Olobatuyi, R. Eisenberg, O. W. Cummings, S. Zhang, et al. Evidence for Common Clonal Origin of Multifocal Lung Cancers J Natl Cancer Inst, April 15, 2009; 101(8): 560 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Baysungur, E. Okur, L. Tuncer, and S. Halezeroglu Sequential right upper sleeve lobectomy and left pneumonectomy for bilateral synchronous lung cancer Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 743 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pennathur, B. Lindeman, P. Ferson, M. Ninan, I. Quershi, W. E. Gooding, M. Schuchert, N. A. Christie, R. J. Landreneau, and J. D. Luketich Surgical resection is justified in non-small cell lung cancer patients with node negative t4 satellite lesions. Ann. Thorac. Surg., March 1, 2009; 87(3): 893 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Oliaro, P. L. Filosso, A. Cavallo, R. Giobbe, C. Mossetti, P. Lyberis, R. C. Cristofori, and E. Ruffini The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 438 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-E. Falcoz Invited commentary Ann. Thorac. Surg., January 1, 2008; 85(1): 209 - 210. [Full Text] [PDF]
|
|
|
|
|
|
J. Rao, R. A. Sayeed, S. Tomaszek, S. Fischer, S. Keshavjee, and G. E. Darling Prognostic Factors in Resected Satellite Nodule T4 Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 934 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Chang, C.-T. Wu, and Y.-C. Lee Surgical treatment of synchronous multiple primary lung cancers: Experience of 92 patients J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 630 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dominguez-Ventura, S. D. Cassivi, M. S. Allen, D. A. Wigle, F. C. Nichols, P. C. Pairolero, and C. Deschamps Lung cancer in octogenarians: factors affecting long-term survival following resection Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 370 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Trousse, F. Barlesi, A. Loundou, A. M. Tasei, C. Doddoli, R. Giudicelli, P. Astoul, P. Fuentes, and P. Thomas Synchronous multiple primary lung cancer: An increasing clinical occurrence requiring multidisciplinary management J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1193 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Port, R. J. Korst, P. C. Lee, A. L. Kansler, Y. Kerem, and N. K. Altorki Surgical Resection for Multifocal (T4) Non-Small Cell Lung Cancer: Is the T4 Designation Valid? Ann. Thorac. Surg., February 1, 2007; 83(2): 397 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kushibe, T. Kawaguchi, Y. Nishimoto, M. Takahama, T. Tojo, and S. Taniguchi Operative indications for lung cancer with satellite lesions. Asian Cardiovasc Thorac Ann, August 1, 2006; 14(4): 316 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Zell, S.-H. I. Ou, A. Ziogas, and H. Anton-Culver Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis Ann. Onc., August 1, 2006; 17(8): 1255 - 1262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Brambilla and S. Lantuejoul Telomerase activation in adenocarcinoma-bronchioloalveolar carcinoma. Eur. Respir. J., June 1, 2006; 27(6): 1079 - 1081. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Zell, S.-H. I. Ou, A. Ziogas, and H. Anton-Culver Epidemiology of Bronchioloalveolar Carcinoma: Improvement in Survival After Release of the 1999 WHO Classification of Lung Tumors J. Clin. Oncol., November 20, 2005; 23(33): 8396 - 8405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. D. Travis, K. Garg, W. A. Franklin, I. I. Wistuba, B. Sabloff, M. Noguchi, R. Kakinuma, M. Zakowski, M. Ginsberg, R. Padera, et al. Evolving Concepts in the Pathology and Computed Tomography Imaging of Lung Adenocarcinoma and Bronchioloalveolar Carcinoma J. Clin. Oncol., May 10, 2005; 23(14): 3279 - 3287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nakata, S. Sawada, M. Yamashita, H. Saeki, A. Kurita, S. Takashima, and K. Tanemoto Surgical Treatments for Multiple Primary Adenocarcinoma of the Lung Ann. Thorac. Surg., October 1, 2004; 78(4): 1194 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-W. Tung, C.-P. Hsu, S.-E. Shai, J.-Y. Hsia, S.-S. Yang, and C.-Y. Chen Surgical feasibility of ipsilateral multifocal non-small cell lung cancer in different lobes: excellent survival in node-negative subgroup Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 1008 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. Roberts, M. Straznicka, P. N. Lara, D. H. Lau, D. M. Follette, D. R. Gandara, and J. R. Benfield Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1597 - 1601. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
